Resveratrol: Difference between revisions

No edit summary
Line 94: Line 94:


<!--T:29-->
<!--T:29-->
A recent study {{pmid|37447275}} in a [[Randomized Controlled Trial|randomized trial]] involving adults aged 55 to 65 compared the effects of resveratrol supplementation to a caloric-restricted diet. Both interventions raised circulating SIRT1 levels and reduced plasma noradrenaline, suggesting cardiovascular benefits. However, the study found differences between the groups in vascular reactions. Specifically, improvements in [[Nitrate-Mediated Vasodilation (NMD)|nitrate-mediated vasodilation (NMD)]] were seen only with caloric restriction, not with resveratrol. Additionally, SIRT1 was linked to enhanced flow-mediated vasodilation (FMD) in men but not in women. This suggests that while resveratrol mirrors some benefits of caloric restriction, it doesn't capture all, especially regarding vascular effects.
A 2023 [[Randomized Controlled Trial|randomized control trial]]{{pmid|37447275}} involving 48 adults aged 55 to 65 compared the effects of resveratrol supplementation to a caloric-restricted diet. Both interventions raised circulating SIRT1 levels and reduced plasma noradrenaline, suggesting cardiovascular benefits. However, the study found differences between the groups in vascular reactions. Specifically, improvements in [[Nitrate-Mediated Vasodilation (NMD)|nitrate-mediated vasodilation (NMD)]] were seen only with caloric restriction, not with resveratrol. Additionally, SIRT1 was linked to enhanced flow-mediated vasodilation (FMD) in men but not in women. This suggests that while resveratrol mirrors some benefits of caloric restriction, it doesn't capture all, especially regarding vascular effects.


==Forms of Resveratrol == <!--T:30-->
==Forms of Resveratrol == <!--T:30-->